ADVANCED BREAST CANCERV

Clinical trials for ADVANCED BREAST CANCERV explained in plain language.

Never miss a new study

Get alerted when new ADVANCED BREAST CANCERV trials appear

Sign up with your email to follow new studies for ADVANCED BREAST CANCERV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for Tough-to-Treat breast cancer: can a drug combo outperform a single pill?

Disease control Recruiting now

This study is for people with advanced or metastatic breast cancer that is estrogen-receptor-positive and HER2-negative, and whose cancer has grown despite prior treatments including a specific type of targeted drug (a CDK4/6 inhibitor). It aims to find out if taking the drug ela…

Matched conditions: ADVANCED BREAST CANCERV

Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

ADVANCED BREAST CANCERV

Get alerted when new ADVANCED BREAST CANCERV trials appear

New hope for Tough-to-Treat breast cancer: can a drug combo outperform a single pill?